Like other health systems across the nation, Baylor Scott & White is facing financial damage caused by the COVID-19 pandemic. The health system spent $85 million to prepare and respond to the pandemic, and it also saw a significant drop in patient volumes.
“We experienced a dramatic drop in patient volumes — between 50 and 90 percent, depending upon where they sought care,” CEO Jim Hinton told employees in a video message, according to The Dallas Morning News.
Those affected by the layoffs will be told this week and paid through June 7, a spokesperson told The Dallas Morning News.
In addition to the layoffs, Baylor Scott & White is furloughing an unspecified number of employees, leaving some open positions unfilled and cutting the pay of about 300 senior leaders, according to the report.
Baylor Scott & White has received about $172 million in federal grants from the $175 billion in relief aid Congress has allocated to hospitals and other healthcare providers to cover expenses or lost revenues tied to the COVID-19 pandemic. The health system also received about $660 million in Medicare advance payments, which must be repaid, according to the report.
Baylor Scott & White is one of more than 260 hospitals and health systems across the nation to furlough or lay off employees in recent months.
More articles on healthcare finance:
20 large hospital networks received $5B in federal bailout funds
10 physician specialties that generate the most revenue for hospitals
Essentia Health lays off 900 employees
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
